Agyemang L - Search Results

1

Low Adherence Achieves High HCV Cure Rates Among People Who Inject Drugs Treated With Direct-Acting Antiviral Agents.

Norton BL, Akiyama MJ, Agyemang L, Heo M, Pericot-Valverde I, Litwin AH. Norton BL, et al. Among authors: agyemang l. Open Forum Infect Dis. 2020 Aug 26;7(10):ofaa377. doi: 10.1093/ofid/ofaa377. eCollection 2020 Oct. Open Forum Infect Dis. 2020. PMID: 33134406 Free PMC article.

2

Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy.

Akiyama MJ, Agyemang L, Arnsten JH, Heo M, Norton BL, Schackman BR, Linas BP, Litwin AH. Akiyama MJ, et al. Among authors: agyemang l. BMC Infect Dis. 2018 Feb 9;18(1):74. doi: 10.1186/s12879-018-2964-5. BMC Infect Dis. 2018. PMID: 29426304 Free PMC article. Clinical Trial.

3

Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy: A Randomized Controlled Trial.

Akiyama MJ, Norton BL, Arnsten JH, Agyemang L, Heo M, Litwin AH. Akiyama MJ, et al. Among authors: agyemang l. Ann Intern Med. 2019 May 7;170(9):594-603. doi: 10.7326/M18-1715. Epub 2019 Apr 9. Ann Intern Med. 2019. PMID: 30959528 Free PMC article. Clinical Trial.

4

Evaluation of contingency management as a strategy to improve HCV linkage to care and treatment in persons attending needle and syringe programs: A pilot study.

Norton BL, Bachhuber MA, Singh R, Agyemang L, Arnsten JH, Cunningham CO, Litwin AH. Norton BL, et al. Among authors: agyemang l. Int J Drug Policy. 2019 Jul;69:1-7. doi: 10.1016/j.drugpo.2019.02.009. Epub 2019 Apr 16. Int J Drug Policy. 2019. PMID: 31003171 Free PMC article.

5

Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment Programs.

Gutkind S, Schackman BR, Morgan JR, Leff JA, Agyemang L, Murphy SM, Akiyama MJ, Norton BL, Litwin AH, Linas BP. Gutkind S, et al. Among authors: agyemang l. Clin Infect Dis. 2020 Mar 17;70(7):1397-1405. doi: 10.1093/cid/ciz384. Clin Infect Dis. 2020. PMID: 31095683 Free PMC article.

6

Low Hepatitis C Reinfection Following Direct-acting Antiviral Therapy Among People Who Inject Drugs on Opioid Agonist Therapy.

Akiyama MJ, Lipsey D, Heo M, Agyemang L, Norton BL, Hidalgo J, Lora K, Litwin AH. Akiyama MJ, et al. Among authors: agyemang l. Clin Infect Dis. 2020 Jun 10;70(12):2695-2702. doi: 10.1093/cid/ciz693. Clin Infect Dis. 2020. PMID: 31346609 Free PMC article. Clinical Trial.

7

Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy.

Cunningham EB, Hajarizadeh B, Amin J, Litwin AH, Gane E, Cooper C, Lacombe K, Hellard M, Read P, Powis J, Dalgard O, Bruneau J, Matthews GV, Feld JJ, Dillon JF, Shaw D, Bruggmann P, Conway B, Fraser C, Marks P, Dore GJ, Grebely J; SIMPLIFY and D3FEAT study groups. Cunningham EB, et al. Clin Infect Dis. 2020 Oct 23;71(7):e115-e124. doi: 10.1093/cid/ciz1089. Clin Infect Dis. 2020. PMID: 31677262 Free article.

8

A Phylogenetic Analysis of Hepatitis C Virus Transmission, Relapse, and Reinfection Among People Who Inject Drugs Receiving Opioid Agonist Therapy.

Akiyama MJ, Lipsey D, Ganova-Raeva L, Punkova LT, Agyemang L, Sue A, Ramachandran S, Khudyakov Y, Litwin AH. Akiyama MJ, et al. Among authors: agyemang l. J Infect Dis. 2020 Jul 6;222(3):488-498. doi: 10.1093/infdis/jiaa100. J Infect Dis. 2020. PMID: 32150621 Free PMC article.

9

Artificial Intelligence Platform Demonstrates High Adherence in Patients Receiving Fixed-Dose Ledipasvir and Sofosbuvir: A Pilot Study.

Litwin AH, Shafner L, Norton B, Akiyama MJ, Agyemang L, Guzman M, Vera T, Heo M. Litwin AH, et al. Among authors: agyemang l. Open Forum Infect Dis. 2020 Jul 20;7(8):ofaa290. doi: 10.1093/ofid/ofaa290. eCollection 2020 Aug. Open Forum Infect Dis. 2020. PMID: 32818140 Free PMC article.

10

Rates of perfect self-reported adherence to direct-acting antiviral therapy and its correlates among people who inject drugs on medications for opioid use disorder: The PREVAIL study.

Pericot-Valverde I, Rennert L, Heo M, Akiyama MJ, Norton BL, Agyemang L, Lumsden B, Litwin AH. Pericot-Valverde I, et al. Among authors: agyemang l. J Viral Hepat. 2021 Mar;28(3):548-557. doi: 10.1111/jvh.13445. Epub 2020 Dec 9. J Viral Hepat. 2021. PMID: 33249689 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters